The arrival of the Retatru vial represents a significant breakthrough in the approach to weight control . This novel medication combines dual mechanisms – activation of the GLP-1 target and inhibition of the DPP-4 factor – offering a distinctive technique for addressing excess weight . Early clinical data suggest substantial efficacy in assisti